Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Kirkpatrick

Showing results (61-70 of 247) with videos related to

Pageof 25
Sort By:
Drugs|March 1, 1992
Interferons 1992. How much of the promise has been realised?M A Volz, C H Kirkpatrick
The Journal of Biological Chemistry|March 23, 2001
Repression of dpp targets by binding of brinker to mad sitesH Kirkpatrick, K Johnson, A Laughon
The Journal of Investigative Dermatology|March 1, 1978
Epidermal proliferation in the defense against experimental cutaneous candidiasisP G Sohnle, C H Kirkpatrick
Experientia|February 15, 1974
Comparison of preparations of erythrocyte membranes and membrane proteins by SDS-gel electrophoresisF H Kirkpatrick, P L LaCelle
Proceedings of the National Academy of Sciences of the United States of America|February 1, 1974
Chemotactic activity in dialyzable transfer factorJ I Gallin, C H Kirkpatrick
Hand Clinics|May 1, 1991
Dacron stabilization of the distal ulnaJ M Hunter, W H Kirkpatrick
Transactions of the American Ophthalmological Society|January 1, 1973
Immunologic reconstitution in a patient with keratoconjunctivitis, superficial candidiasis and hypoparathyroidism: the role of immunocompetent lymphocyte transfusion and transfer factorV G Wong, C H Kirkpatrick
Chest Surgery Clinics of North America|March 18, 1999
Recognition of the immunocompromised patientM G Gutierrez, C H Kirkpatrick
Obstetrics and Gynecology|October 23, 2010
Does standardization of care through clinical guidelines improve outcomes and reduce medical liability?Douglas H Kirkpatrick, Ronald T Burkman
Cellular Immunology|December 1, 1976
Serial transfer of delayed hypersensitivity with dialyzable transfer factorC H Kirkpatrick, T K Smith
Pageof 25

Showing results (61-70 of 247) with videos related to

Sort By:
Pageof 25
Drugs|March 1, 1992
Interferons 1992. How much of the promise has been realised?M A Volz, C H Kirkpatrick
The Journal of Biological Chemistry|March 23, 2001
Repression of dpp targets by binding of brinker to mad sitesH Kirkpatrick, K Johnson, A Laughon
The Journal of Investigative Dermatology|March 1, 1978
Epidermal proliferation in the defense against experimental cutaneous candidiasisP G Sohnle, C H Kirkpatrick
Experientia|February 15, 1974
Comparison of preparations of erythrocyte membranes and membrane proteins by SDS-gel electrophoresisF H Kirkpatrick, P L LaCelle
Proceedings of the National Academy of Sciences of the United States of America|February 1, 1974
Chemotactic activity in dialyzable transfer factorJ I Gallin, C H Kirkpatrick
Hand Clinics|May 1, 1991
Dacron stabilization of the distal ulnaJ M Hunter, W H Kirkpatrick
Transactions of the American Ophthalmological Society|January 1, 1973
Immunologic reconstitution in a patient with keratoconjunctivitis, superficial candidiasis and hypoparathyroidism: the role of immunocompetent lymphocyte transfusion and transfer factorV G Wong, C H Kirkpatrick
Chest Surgery Clinics of North America|March 18, 1999
Recognition of the immunocompromised patientM G Gutierrez, C H Kirkpatrick
Obstetrics and Gynecology|October 23, 2010
Does standardization of care through clinical guidelines improve outcomes and reduce medical liability?Douglas H Kirkpatrick, Ronald T Burkman
Cellular Immunology|December 1, 1976
Serial transfer of delayed hypersensitivity with dialyzable transfer factorC H Kirkpatrick, T K Smith
Pageof 25